Electrical Stimulation of the Mandibular Nerve for Pain and Function Management in Temporomandibular Disorders
NCT ID: NCT06265636
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2024-02-17
2027-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The TMJ and masticatory muscles are innervated by the auriculotemporal branch and the mandibular nerve (V3), a branch of the trigeminal nerve. An estimated 60% to 70% of the population shows signs of TMD, of which up to 12% report intense symptoms requiring treatment.
Percutaneous electrical nerve stimulation (PENS) could be a clinically relevant therapy in TMD patients applied through minimally invasive physiotherapy. To our knowledge, there are no trials evaluating the non-surgical clinical efficacy of PENS on the mandibular nerve.
The project's objective is to assess the effectiveness of PENS on the mandibular nerve in this type of condition.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life and Sleep in Patients With Temporomandibular Disorders
NCT07056725
Treatment of Temporomandibular Disorders
NCT01187316
A Combined Treatment of Manual Therapy and Nervous Vagus Stimulation in Patients With Myogenic Temporomandibular Disorders
NCT05272488
Effect of Noninvasive Neuromodulation on Chronic Pain
NCT03285685
Assessment of Nociceptive Processing Among Patients With Temporo-mandibular Disorders
NCT04086732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Temporomandibular Disorder often coexists with other medical conditions, such as headaches. The most common diagnoses are myofascial pain, followed by disc displacement with reduction and arthralgia. Prevalence ranges from 3% to 15%, with new case rates between 2% and 4%. Prognosis for myofascial TMD varies, with studies indicating persistence, remission, and relapse.
The economic cost associated with TMD is significant, with studies revealing considerable expenses on treatments. The multifactorial pathophysiology of myofascial pain is influenced by bruxism, stress, psychological conditions, and fibromyalgia. Risk factors include genetics, psychological stress, and parafunctional habits. Clinical manifestations include pain, decreased jaw mobility, and additional symptoms in the head and neck. Diagnosis involves physical examination, palpation of muscles and joints, and imaging tests such as magnetic resonance imaging. Specific diagnostic criteria have been proposed.
Conservative treatment, including physiotherapy, manual therapy, exercises, splints, and pharmacological modalities, is the primary option. However, there are limitations in the effectiveness of some approaches. Physiotherapy is considered effective by 72% of respondents in the United Kingdom.
The musculoskeletal system related to the temporomandibular joint (TMJ) consists of masticatory, facial expression, and neck muscles, playing specific roles in jaw movement. Elevator muscles (masseter, temporal, and medial pterygoid) close the mouth, depressors (digastric and lateral pterygoid) open it, protractors (temporal and lateral pterygoid) move it forward, and retractors (masseter and medial pterygoid) move it backward. Facial expression and neck muscles contribute to additional functions.
Motor innervation of the TMJ comes from the trigeminal nerve, specifically its mandibular branch (V3), which also innervates masticatory muscles. This nerve divides into branches such as the ophthalmic, maxillary, and mandibular, providing sensitivity to different areas of the face, mouth, and jaw.
Blood supply to the TMJ occurs through the superficial temporal artery and the mandibular artery, supplying blood to the skin, muscles, and surrounding joint structures.
Regarding the biomechanics and functionality of the TMJ, its complexity and crucial role in jaw movements such as chewing, speaking, and yawning are emphasized.
Manual therapy, specifically cervico-mandibular therapy, has shown significant improvements in disability related to temporomandibular disorders (TMD). The combination of manual therapy for the orofacial region and the cervical spine has proven to be more effective than home exercises or cervical treatment alone.
Therapeutic exercise in the TMJ has demonstrated moderate short-term effects and variable long-term effects in reducing pain and improving range of motion in patients with TMJ dysfunction. Passive and active stretches, as well as postural exercises, are useful for increasing range of motion and reducing pain.
Percutaneous electrical nerve stimulation (PENS) emerges as a relevant option for managing pain in TMD patients. PENS, applied through ultrasound-guided needles, can influence orofacial pain and jaw movement, offering analgesic benefits through peripheral and central mechanisms. PENS is considered a minimally invasive intervention and has been successfully used in chronic pain treatment.
In summary, a detailed understanding of the anatomy, function, innervation, and vascularization of the TMJ, combined with therapeutic approaches such as manual therapy, exercise, and PENS, is essential for comprehending and effectively addressing temporomandibular disorders.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
Manual Therapy, exercise and percutaneous electrical nerve stimulation.
Percutaneous nerve stimulation
Percutaneous nerve stimulation (PENS) involves inserting a dry needling needle through muscle tissue until it reaches a nerve branch. At this point, a bipolar TENS current with different parameters is applied to the needle with the goal of improving the patient's pain perception.
Manual therapy
Digital pressure techniques in muscle areas with the aim of reducing the perception of stiffness and pain
exercise
Exercises for improving mandibular mobility, occlusion coordination and regulation of temporomandibular muscle tone
Control Group
Manual Therapy, exercise.
Manual therapy
Digital pressure techniques in muscle areas with the aim of reducing the perception of stiffness and pain
exercise
Exercises for improving mandibular mobility, occlusion coordination and regulation of temporomandibular muscle tone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous nerve stimulation
Percutaneous nerve stimulation (PENS) involves inserting a dry needling needle through muscle tissue until it reaches a nerve branch. At this point, a bipolar TENS current with different parameters is applied to the needle with the goal of improving the patient's pain perception.
Manual therapy
Digital pressure techniques in muscle areas with the aim of reducing the perception of stiffness and pain
exercise
Exercises for improving mandibular mobility, occlusion coordination and regulation of temporomandibular muscle tone
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with myofascial pain from temporomandibular disorder (TMD) at the time, diagnosed according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).
* Absence of temporomandibular disc displacement with or without reduction.
* Pain in the masticatory muscles associated with limited mouth opening (\<40mm).
* Good general health (absence of chronic diseases that may affect the temporomandibular joint or masticatory muscles).
* Written consent to participate in the study.
Exclusion Criteria
* Undergone surgical procedures performed in the craniocervical region and degenerative neurological diseases.
* Sudden illness of the patient that prevented participation in the study.
* Will to end participation in the study.
* Less than 2 weeks of evolution.
* Inability to understand instructions or sign the informed consent.
* Minor patients.
* Regular medication, such as muscle relaxants, anticonvulsants, antidepressants, or anxiolytics
* Facial paralysis.
* Presenting a disease or infectious/inflammatory process of dental origin.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Rey Juan Carlos
OTHER
OrigenKinesis fisioterapia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hector Mardomingo Medialdea
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Origenkinesis Fisioterapia
Alcorcón, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006202325523
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.